M&As this week: Augment Investments, Recordati

2nd June 2016 (Last Updated June 2nd, 2016 18:30)

Augment Investments has announced its acquirement of an additional 10.032% stake in Pharmstandard OJSC, from Bristley Enterprises, to become a 79.8% stake holder in the company, upon the completion of the transaction.

Augment Investments has announced to acquire additional 10.032% stake in Pharmstandard OJSC, from Bristley Enterprises, to become a 79.8% stake holder in the company, upon the completion of the transaction.

According to the transaction, Augment will hold 15.2m global depository receipts (GDS) of Pharmstandard.

Pharmaceutical company Recordati S.p.A has invested $144.6m to acquire 100% share capital of Italchimici S.p.A.

The company expects that the acquisition will help expand its gastroenterology products, as well as strengthen its portfolio.